Hierarchial silica oxidation dehydrogenation catalyst
AssigneeImam Abdulrahman Bin Faisal University
InventorB. Rabindran JERMY
Life of this patent
Estimating the term…
Abstract
A nanotherapeutic supported by a hierarchical silica composite with dual imaging capability (e.g. fluorescence and magnetic resonance imaging), a method of preparing the nanotherapeutic, and a method of treating cancer. Also disclosed is a method of oxidatively dehydrogenating ethane using a catalytic system supported by a hierarchical silica composite.
Claims6
(canceled)
The catalyst of claim 20, wherein the hierarchical silica composite has a silicon to aluminum molar ratio in a range of 1,000:1 to 3,000:1.
The catalyst of claim 20, wherein the mesopores have a pore volume in the range of 0.5-1.5 cm3/g and a surface area in the range of 800-1,600 m2/g.
4-19. (canceled)
An oxidative dehydrogenation catalyst, comprising:
- a hierarchical silica composite comprising
- a stereoregular MCM-41 ordered arrangement of uniformly-sized mesopores with diameters in a range of 2-50 nm and mesopore walls having a thickness of about 1 to about 5 nm,
- a stereoregular monodispersed spherical silica with a particle size of about 80 nm with a pore diameter of 10-20 nm, and
- a stereoregular MFI silicalite ordered arrangement of uniformly-sized micropores with diameters of less than 2 nm located within the mesopore walls;
- and
- an active catalytic material impregnated on the hierarchical silica composite, the active catalytic material comprising
- nickel, nickel oxide, and/or nickel and iron mixed metal oxide, and
- at least one cation dopant selected from the group consisting of Nb5+, Al3+, Ti4+, Ta5+, and Bi5+ and/or oxides thereof.
Dependencies are inferred from the claim text.